Skip to content

Bausch + Lomb BLCO Accounts Receivable

Accounts Receivable at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.72B+10.6%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$809.2M+3.6%
Glaukos logo
GlaukosGKOS
$119.69M+67.3%
AbbVie logo
AbbVieABBV
$12.48B0.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$100.34M+60.7%
Warby Parker logo
Warby ParkerWRBY
$1.76M+19.6%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.43B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's accounts receivable?
Bausch + Lomb (BLCO) reported accounts receivable of $1.11B in Q1 2026.
How has Bausch + Lomb's accounts receivable changed year-over-year?
Bausch + Lomb's accounts receivable increased by 9.8% year-over-year, from $1.01B to $1.11B.
What is the long-term trend for Bausch + Lomb's accounts receivable?
Over 4 years (2021 to 2025), Bausch + Lomb's accounts receivable has grown at a 55.5% compound annual growth rate (CAGR), from $752M to $4.4B.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.